👋 We'll be at AES 2024!

From December 6-10th in LA, come and talk to us in booth 2132.

👋 We'll be at AES 2024!

From December 6-10th in LA, come and talk to us in booth 2132.

👋 We'll be at AES 2024!

From December 6-10th in LA, come and talk to us in booth 2132.

Innovation in neonatal neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

Innovation in neonatal neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

Innovation in neonatal neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

Innovation in neonatal neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

Healthcare professionals currently struggle to answer this critical question:

Healthcare professionals currently struggle to answer this critical question:

Is this newborn's brain health at risk?

Is this newborn's brain health at risk?

20% of newborns

require assessment for brain injury arising from complications

at birth.

>80% of hospitals

can't perform neonatal EEG, the gold standard for newborn neurological assessment.

50% of cerebral palsy cases

are undetected at birth, leading to challenges that arise from late diagnoses.

Electroencephalography (EEG) is a direct measure of the electrical activity of the brain.

Patterns in the EEG provide real-time information about brain function and identify babies at risk of brain injury quickly. However, recording a clinical EEG is expensive, time consuming, and requires expert interpretation. It is generally only available in specialist centres. As a result, many newborns are currently not assessed at birth, missing critical opportunities for early intervention and treatment.

Missed diagnoses can lead to a range of challenges.

These include learning difficulties, physical disabilities, and emotional or behavioural issues that may persist throughout an individual's life. The impact goes beyond the individual, as families often endure emotional stress and financial strain due to long-term care needs. Additionally, healthcare systems face increased demand for specialised services and support.

CergenX aims to change this so that every newborn has timely access to expert brain function assessment.

CergenX aims to change this so that every newborn has timely access to expert brain function assessment.

Introducing:

Introducing:

CergenX Wave

CergenX Wave

CergenX Wave is our AI-powered innovation in neonatal neuroprotective care, revolutionising the assessment of newborn brain function.

CergenX Wave is our AI-powered innovation in neonatal neuroprotective care, revolutionising the assessment of newborn brain function.

15 minute test

Set up device, record EEG and get a result in just 15 minutes.

Objective decision support

Simple & easy to use

Automated AI EEG assessment

For use by all clinicians

15 minute test

Set up device, record EEG and get a result in just 15 minutes.

Objective decision support

Simple & easy to use

Automated AI EEG assessment

For use by all clinicians

15 minute test

Set up device, record EEG and get a result in just 15 minutes.

Objective decision support

Simple & easy to use

Automated AI EEG assessment

For use by all clinicians

15 minute test

Set up device, record EEG and get a result in just 15 minutes.

Objective decision support

Simple & easy to use

Automated AI EEG assessment

For use by all clinicians

Our network

Our network

Our network

Our network